Calithera Biosciences (NASDAQ:CALA) Coverage Initiated at StockNews.com

Posted by on Jan 21st, 2025

StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA – Get Free Report) in a report issued on Sunday. The brokerage set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

CALA opened at $0.00 on Friday. Calithera Biosciences has a 12-month low of $0.00 and a 12-month high of $0.12.

About Calithera Biosciences

(Get Free Report)

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.

Featured Articles

Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.